Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy.
            Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy. J Am Coll Cardiol. 2025 May 27; 85(20):1911-1923.
            PMID: 40398971
          
            Mitigating Post-operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study.
            Mitigating Post-operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study. J Card Fail. 2025 Feb 13.
            PMID: 39954845
          
            Early and Late Outcomes of Ambulatory Counter Pulsation Devices as a Bridge to Heart Transplantation.
            Early and Late Outcomes of Ambulatory Counter Pulsation Devices as a Bridge to Heart Transplantation. Cardiology. 2024 Nov 29; 1-8.
            PMID: 40293434
          
            Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial.
            Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial. Circulation. 2025 Mar 04; 151(9):601-611.
            PMID: 39556242
          
            Clinical and Echocardiographic Features of Individuals With Cardiac Amyloidosis at Risk for Future Thrombus Formation.
            Clinical and Echocardiographic Features of Individuals With Cardiac Amyloidosis at Risk for Future Thrombus Formation. J Am Soc Echocardiogr. 2025 Feb; 38(2):135-137.
            PMID: 39481665
          
            Dynamic assessment of left ventricular coupling and myocardial reserve in patients with cardiogenic shock.
            Dynamic assessment of left ventricular coupling and myocardial reserve in patients with cardiogenic shock. Eur Heart J Open. 2024 Sep; 4(5):oeae072.
            PMID: 39328214
          
            Perivascular Amyloid Deposition in Immunoglobulin Light Chain Cardiac Amyloidosis and Its Implications on Echocardiographic Cardiac Remodeling.
            Perivascular Amyloid Deposition in Immunoglobulin Light Chain Cardiac Amyloidosis and Its Implications on Echocardiographic Cardiac Remodeling. J Am Soc Echocardiogr. 2024 Oct; 37(10):1010-1012.
            PMID: 38960211
          
            Defining echocardiographic predictors of outcome in cardiac amyloidosis by subtype.
            Defining echocardiographic predictors of outcome in cardiac amyloidosis by subtype. Curr Probl Cardiol. 2024 Sep; 49(9):102729.
            PMID: 38945183
          
            Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study.
            Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study. Eur Heart J Cardiovasc Imaging. 2024 05 31; 25(6):754-761.
            PMID: 38243591
          
            New-Onset Neurosarcoidosis Following Heart Transplant for Cardiac Sarcoidosis.
            New-Onset Neurosarcoidosis Following Heart Transplant for Cardiac Sarcoidosis. JACC Case Rep. 2024 Jun 05; 29(11):102358.
            PMID: 38765201
          
